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Abstract: 
Background: Discrete Choice Experiment [DCE], Conjoint Analysis [CA], or Adaptive Conjoint Analysis 
[ACA] methods are increasingly applied to obtain patient, clinician or community preferences in 
nephrology. This study systematically reviews the abovementioned published choice studies 
providing an overview of the issues addressed, methods, and findings. 
Methods: Choice studies relating to nephrology were identified using electronic databases, including 
Medline, Embase, PsychINFO and Econlit from 1990 to 2015. For inclusion in the review, studies had 
to primarily relate to kidney disease and include results from statistical (econometric) analyses of 
respondents’ choice or preference. Studies meeting the inclusion criteria were assessed against a 
range of systematic review criteria, and methods and results summarised. 
Results: We identified 14 eligible studies from Europe, Australasia, North America, and Asia, 
reporting preferences for treatment or screening, patient experiences, quality of life, health 
outcomes and priority setting frameworks. Specific contexts included medical interventions in kidney 
transplantation and renal cell carcinoma, health policies for organ donation and allocation, dialysis 
modalities and end-of-life care; using a variety of statistical models. The characteristics of ‘time’ (i.e. 
transplant waiting time, dialysis hours, transport time) and ‘quality of life’ (pre and post-transplant, 
or pre and post-dialysis) consistently influenced patient and clinician preferences across the choice 
studies. 
Conclusions: Discrete choice experiments are increasingly used to obtain information about key 
preferences in kidney transplantation and dialysis. These study methods provide quantitative 
information about respondents’ trade-offs between conflicting clinical and policy objectives, and can 
establish how preferences vary among stakeholder groups. 
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Keywords: Conjoint Analysis, Discrete Choice Experiment, Dialysis, Transplantation, Kidney Disease, 
Preferences. 
Summary sentences: 
Discrete Choice Experiments and Conjoint Analyses are increasingly used to study preferences in 
nephrology about organ donation and organ allocation decisions, and dialysis modality preferences.  
Such choice studies can assess preferences for treatments and policies from a variety of 
stakeholders including nephrologists, patients, caregivers, and the broader community.  
They highlight the trade-offs people make between multiple objectives in transplantation and 
dialysis care. 
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Introduction:  
Every day in nephrology, clinicians and patients face difficult decisions about treatment options, best 
practice care, and the ‘right’ use of resources.  Discrete Choice Experiments (DCE), Conjoint Analysis 
(CA) and Adaptive Conjoint Analysis (ACA) studies systematically quantify preferences for treatment 
alternatives, and measure the trade-offs people make between the characteristics of each 
alternative. They are grounded in Lancaster’s theory of demand,[1] which assumes demand for 
goods and services, including health services can be related to demand for individual characteristics 
of the goods or services. Further theoretical details[2] are provided in the technical appendix (see 
Appendix A.3).  
 
Systematic reviews of the application of DCE, CA, or ACA literature in healthcare from 1990 to 
2012[3, 4] reported rapid growth in the application of such techniques from an average of just over 
3 per year between 1990-2000 to 48 per year 2009-2012. The aims of this study were to review the 
nephrology DCE, CA, and ACA literature published since 1990; to highlight the key trade-offs 
patients, clinicians, and other groups make in this context; and undertake a detailed systematic 
outline of study methodology.  
 
Methods 
Using keywords including (Nephrology OR Kidney OR Renal) AND (Discrete Choice OR Conjoint 
Analysis) in Medline, Embase, PsychINFO and Econlit from 1st January 1990 to 31st December 2015 
we identified studies that used DCE, CA, or ACA methodology, applied to any research question 
relating to nephrology.  Primary studies were included in the systematic review if they contained 
empirical (statistical or econometric) analyses; study protocols, conference abstracts, reviews and 
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opinions pieces were excluded. We followed criteria used in two previous reviews for study designs 
of this type,[3, 4] and further details are within the electronic appendices.  
 
DCE and CA survey studies involve a comparison between 2 or 3 alternatives. The characteristics 
(known as attributes) of these alternatives are identical, but levels of characteristics change. Figure 1 
provides an example of a DCE scenario, and Table 1 displays all of the attribute levels. With both DCE 
and CA formats, the range of choices faced is pre-determined before choices are made. In contrast, 
ACA methods use similar choices, but are ‘adaptive’ because scenarios are generated by an adaptive 
computer programme taking into account previous responses. These approaches (DCE, CA, and ACA) 
have an advantage over other ranking or rating techniques such as Likert scales because they 
facilitate a relative quantitative valuation of different characteristics as opposed to trying to value or 
rank the alternative as a ‘whole.’ 
FIGURE 1: Example of a choice set (scenario) in a DCE of nephrologists’ preferences for dialysis 
recommendation in elderly ESKD patients used in the reviewed DCE analysis cited in the reference 
list by Foote et al 2014.  
 
 
 
 
 
The attribute levels were allowed to vary across choice sets as set out in table 1. 
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Table 1: Characteristics and their levels in the 12 choice sets (scenarios)  
 
Characteristics Levels 
Patient age 75  
85  
90 
Patient gender Male  
Female 
Patient cognitive state Normal  
Somewhat impaired 
Greatly impaired 
Patient comorbid burden Diabetes  
Diabetes/coronary artery disease 
Diabetes/CVD*/peripheral vascular disease 
Patient life expectancy (with dialysis) 1 year  
3 years  
5 years 
Patient QOL (baseline) Low 
Medium 
High 
Patient change in QOL (with dialysis) Expected to decrease 
Expected to be maintained 
Expected to improve 
Family/close person support Low 
Medium 
High 
Patient inclination to dialyse Inclined 
Undecided  
Disinclined 
Family/close person inclination for patient to dialyse Inclined 
Undecided  
Disinclined 
 
*CVD = cerebrovascular disease 
 
 
Results 
We identified 14 eligible studies from Europe, Australia, New Zealand, North America, and Asia, that 
reported preference information for a wide range of stakeholder groups including patients, 
clinicianshealthcare professionals, caregivers, donors, relatives of deceased donors, and the general 
community. Studies elicited preferences for medical interventions in kidney transplantation, health 
policies for organ donation and allocation, dialysis modalities, and end-of-life care. Methodological 
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criteria for each study are listed in Tables S1-S15. We provide information about the country of 
analysis, number of respondents, and category or categories of primary choice studies (Table 2), as 
reported in previous systematic reviews of DCE, CA, and ACA literature in healthcare.  
 
Transplantation studies 
One CA in the United States among 175 patients,[5] investigated the acceptability of receiving a 
kidney from a donor at increased risk of blood-borne viral infection (DIRVI). The analysis contained 3 
attributes relating to HIV infection risk, donor age, and transplant waiting time. Findings suggested 
longer waiting time (P<0.01), lower donor age (P<0.01), lower donor HIV risk, participant being on 
dialysis (P<0.01), and older participant age (P=0.04), significantly affected preferences. Overall 42 
respondents (24%) would not accept a DIRVI kidney in any scenario; 103 (59%) would accept a DIRVI 
kidney in some scenarios; and 31 (18%) would accept a DIRVI kidney in all scenarios. Patients were 
more likely to accept DIRVI kidneys when the waiting time was longer (P<0.01); the donor was 
younger (P<0.01); and HIV risk was lower (P<0.01). Patients on dialysis (P<0.01) and older patients 
(P<0.01) would be more likely to accept DIRVI kidneys. 
 
Another DCE  in the UK assessed preferences of 908 patients for 6 kidney transplant allocation 
criteria.[6] Findings were presented in terms of a marginal rate of substitution (MRS) that is, a trade-
off relative to waiting an additional year for a kidney transplant. Results suggested that among 
patients who were not from an ethnic minority group, all attributes were significant. Findings 
suggested a pronounced preference for prioritising patients with moderate not severe diseases 
affecting life expectancy (MRS = 15.93), but paradoxically no preference for ‘no diseases versus 
moderate diseases,’ affecting life expectancy. Other significant attributes included a 1% 
improvement in kidney survival (MRS = 1.54); having an extra dependent adult or child (MRS = 1.35);  
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Table 2. Country of analysis and standardised category (or categories)* of primary choice studies. 
Authors. Country of analysis  Number of 
respondents 
 
A. Patient 
Consumer 
Experience 
B. Valuing 
Health 
Outcomes. 
C. Investigating 
trade-offs 
health 
outcomes and 
patient or 
consumer 
experience 
factors. 
D. 
Estimating 
utility 
weights 
within the 
QALY 
framework 
E. Job Choices 
for preferences 
relating to 
medical posts 
or healthcare 
human 
resource policy. 
F. 
Developin
g priority 
setting 
framewor
ks. 
G. Health 
Professionals 
preferences for 
treatment or 
screening 
options for 
patients 
H. Other 
Clark et al 
(2009) UK 
908 patients 
- -  - -  - - 
Clark et al 
(2012) 
UK 
908 patients,41 
Carers, 113 
Healthcare 
professionals 
- -  - -   - 
Davison et al 
(2010) Canada 
169 patients, 29 
Carers  - - - -   - 
Foote et al 
(2014) 
Australia and New 
Zealand 
159 
Nephrologists - - - - - -  - 
Halpern et al 
(2004) USA 
126 patients 
- -  - - - - - 
Howard et al 
(2015a) Australia 
2051 
Community 
respondents 
- -  - -  - - 
Howard et al 
(2015b) Australia 
2005 
Community 
respondents 
- - - - - - -  
Kjaer et al 
(2012) Greenland 
206 Public 
preferences - - - - -  - - 
Mohamed et 
al (2011) 
USA (+respondents 
from Australia, 
Canada, UK) 
138 patients 
- -  - - - - - 
Morton et al 
(2012a) Australia 
105 Patients, 73 
Carers - -  - - - - - 
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Morton et al 
(2012b) Australia 
105 Patients 
- -  - - - - - 
Park et al 
(2012) 
South Korea 
120 Patients, 52 
Family 
members, 272 
Healthcare 
professional 
- -  - - -  - 
Reese et al 
(2010) USA 
175 patients 
- -  - -  - - 
Whitman et al 
(2013) USA 
305 
Nephrologists - - - - - -  - 
Total   1 0 9 0 0 6 5 1 
A blank cell suggests that the paper does not fulfil this criterion, whereas the symbol  implies that the criterion is met. 
* Standard categories used in prior systematic reviews of DCE studies in the healthcare literature.  
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a one-year reduction in recipient age (MRS = 0.16); having no disease other than kidney disease 
affecting quality of life (MRS = -2.48); and having moderate rather than severe diseases affecting 
quality of life (MRS = 4.08), as was transplant waiting time (MRS = 1). Those who were not from 
ethnic minorities would prioritise transplants to patients with a better tissue match to the donor, 
whereas non-white ethnic minorities would not.  
 
In a later analysis[7] the same DCE was applied to 908 patients, 41 carers, 113 healthcare 
professionals, and 48 live donors /relatives of deceased donors. Similarly, findings suggested a 
pronounced preference for prioritising patients with moderate, not severe, diseases affecting life 
expectancy (MRS = 15.32). A 1% improvement in kidney survival (MRS = 1.41); having an extra 
dependent adult or child (MRS = 1.43); a one year reduction in recipient age (MRS = 0.16); having no 
diseases other than kidney disease affecting quality of life (MRS = -2.73); and having moderate 
rather than severe diseases affecting quality of life (MRS = 4.18) were also valued relative to a 1 year 
transplant wait. Healthcare professionals’ valued prioritising patients with better tissue matches 
lower than patients but prioritised younger recipients and those with dependents higher. They 
prioritised those with none versus moderate diseases, affecting life expectancy whereas patients did 
not, and they prioritised those with moderate rather than severe diseases higher than patients. 
Assessment of preferences for live donors or relatives of deceased donors, and carers, was limited 
by small sample sizes.  
 
A DCE assessed community preferences for the allocation of donor organs for transplantation 
(including kidneys and other organs) in Australia[8] using a sample of 2,051 community respondents. 
This study had 15 attributes. Findings suggested most of the variables for transplant allocation 
criteria were significant at the 0.001 level, with the exception of having previous cancer, which was 
significant at the 1% level (p=0.01); recipient sex, and having diabetes which were non-significant 
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(p>0.05). Mixed logit analysis suggested that allocation to people aged 5 (β= 0.662), 15 (β= 0.562), or 
25 (β= 0.380), was preferred compared to recipients aged 40 (β= -0.163), whilst allocation to those 
aged 55 (β= -0.277), or 70 (β= -1.164), was less preferred to those aged 40. Those with previous 
transplant(s) (β= -0.146), and those who did not follow their doctor’s advice (β= -0.059), were given 
a lower priority. Those with caring responsibilities (β= 0.351), or whose family were registered as 
donors (β= 0.186), were prioritised more; those with long waiting times were prioritized (β= 0.042); 
those with lower life expectancy without a transplant (β= -0.87), and higher life expectancy post-
transplant (β= 0.058), were prioritised; those with lower quality of life without a transplant (β= 
0.057), and higher quality of life post-transplant (β= 0.112), were prioritised. Those with 
comorbidities such as diabetes and previous cancer (β=- 0.088), and hepatitis and other viral 
diseases which were being treated (β= -0.217), were prioritised less. Compared to non-smokers, ex-
smokers (β= -0.265), or current smokers (β= -0.751), were given lower priority, as were those 
consuming alcohol occasionally (β= -0.093) or more than 5 nights a week (β= -0.350).  Obese people 
(β= -0.266), compared to non-obese people were also given lower priority. 
 
A second DCE analysis[9] investigated the preferences of 2,005 Australian community respondents 
for organ donation policy. The impact of 8 policy attributes was assessed. The analysis suggested 
that the type of donation consent system and availability of family priority for transplants in the 
future did not influence community preferences. Results were presented in terms of odds ratios 
(OR), whereby an OR >1 for an attribute suggested that as the level of the attribute increased, policy 
alternative A was preferred over policy B. Respondents favoured a policy where the donor's family 
still had some, but not all, involvement in the final donation decision; however a policy where family 
always has the final say (OR), 0.25; 95% confidence interval [95%CI], 0.21-0.28), or never has the 
final say (OR, 0.50; 95%CI, 0.44-0.56) was significantly less preferred. Respondents also preferred a 
policy where the registration process was easy (OR, 1.16; 95%CI, 1.09-1.24), e.g. sending all adults a 
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registration form and reply paid envelope; where reconfirmation of donation intent was less 
frequent (for example, annual confirmation: OR, 0.88; 95%CI, 0.78-0.98); where there was a direct 
payment (OR range 1.19-1.32) or reimbursement of funeral expenses (OR range 1.18-1.55); and 
where there was some formal recognition of donation, for example, a letter to the donor's family 
(OR, 1.14; 95%CI, 1.04-1.27), or the donor's name placed on a memorial (OR, 1.29; 95%CI, 1.14-
1.45).  
 
Dialysis studies 
A CA in the US examined the willingness of 126 patients to switch dialysis modality from 
conventional to more frequent dialysis.[10] The authors established the impact of 4 attributes 
including life expectancy, quality of life, the annual number of hospitalisations, and transport time. 
All 4 attributes were significantly associated with a willingness to switch to daily haemodialysis in the 
hypothesised direction. Findings showed that 44% of respondents receiving conventional 
haemodialysis 3 times per week would not switch to daily 6 times per week haemodialysis regardless 
of the health benefits. Of the 56% who said they might switch to this regimen, the majority would 
only switch for substantive health benefits. 
 
A second dialysis DCE investigated public preferences among 206 respondents for the location of 
dialysis facilities for residents of Greenland.[11] This involved 3 attributes including recruitment of 
nephrologists, location of patient accommodation, and increase in taxation required for dialysis. All 
the variables relating to these 3 attributes were significant at the 1% level, and standard deviations 
were significant for all random parameter logit variables (indicating statistically significant 
preference heterogeneity - see appendix A.2 for details). A key finding was that hypothetical 
alternatives involving treatment in Greenland (versus treatment in Denmark) were chosen in nearly 
two-thirds of cases, implying a ‘slight tendency’ to favour treatment in Greenland despite increased 
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taxation. Respondents were willing to pay 30 Euro more in increased taxes per person per year to 
see a permanent nephrologist than a non-permanent (visiting) nephrologist. The provision of 
accommodation required to undertake dialysis in apartments was valued at 70 Euro, and in hotels at 
88 Euro of increased taxation per person per year. The statistically significant model constant, 
implied an overall preference in favour of dialysis in Greenland (valued at 63 Euros).  
 
A DCE in Australia assessed preferences for dialysis modality among 105 pre-dialysis patients and 73 
caregivers.[12] Informed by preliminary research,[13, 14] 3 treatment alternatives for home dialysis, 
in-centre dialysis and non-dialytic conservative care were created. The alternatives were described 
by 7 attributes including average survival time, number of visits per week to hospital for dialysis, 
ability to travel or ‘go away’ on short trips, hours of dialysis per treatment, time of day the dialysis 
can be undertaken, provision of a transport service to attend dialysis or doctors’ appointments, and 
whether there was flexibility to change dialysis and times. Findings reported home-based dialysis 
was chosen 65% of the time and in-centre dialysis 35% of the time. Comparing dialysis versus 
conservative care, 90% of respondents chose a dialysis option and 10% chose a non-dialysis 
(conservative care) option.  In the main analysis for patients, 2 variables for home-based dialysis (life 
expectancy [OR, 1.68], travel restrictions [OR, 0.37]) were significant with another 8 variables non-
significant. Similarly, 1 attribute for in-centre haemodialysis (longer hours [OR, 2.02] was significant. 
Among caregivers, home dialysis was chosen 72% of the time, in-centre dialysis 25% of the time, and 
conservative care in 3%. Moreover, 3 out of 9 variables relating to home dialysis compared to 
conservative care (life expectancy [OR, 1.82], dialysis at night [OR, 0.03], and travel restrictions with 
home dialysis [OR, 0.43]) were significant. Similarly, amongst caregivers when comparing in-centre 
haemodialysis with conservative care 2 out of 11 variables (dialysis at night time [OR, 0.03] and 
hours with in centre dialysis [OR, 2.67]) were significant. All significant variables were in the 
expected direction. 
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A second analysis from the same research teams[15] elicited preferences among 105 respondents 
for dialysis versus conservative non-dialytic care in Australia. Findings suggested patients preferred 
dialysis to conservative care if dialysis increased average life expectancy (OR, 1.84; 95%CI, 1.57-
2.15), if they could dialyse during the day or evening rather than during the day only (OR, 8.95; 
95%CI, 4.46-17.97), and if subsidised transport was available (OR, 1.55; 95%CI, 1.24-1.95). Patients 
were less likely to choose dialysis over conservative care if more hospital visits were required (OR, 
0.70; 95%CI, 0.56-0.88), and with more restrictions on travel (OR, 0.47; 95%CI, 0.36-0.61). Patients 
would forgo 7 months life expectancy to reduce the number of visits to the hospital, and 15 months 
to increase their ability to travel. 
 
Another DCE[16] looked at the preferences of 159 Australian nephrologists for dialysis in elderly 
patients with end-stage kidney disease. The DCE included 10 attributes. Findings indicated all patient 
characteristics (except sex) significantly affected the likelihood of nephrologists recommending 
dialysis. Nephrologists were more likely to recommend dialysis for patients with preserved cognition 
(OR, 68.3; 95%CI, 33.4-140.0), lower comorbidity (OR, 2.1; 95%CI, 1.1-4.1), increased life expectancy 
(OR, 2.8; 95%CI, 2.1-3.7), high current QOL (OR, 2.8; 95%CI, 2.0-3.8), and positive patient and family 
dialysis inclination (OR, 27.5; 95%CI, 16.2-46.8 and OR, 2.0; 95%CI, 1.3-3.3, respectively). 
Nephrologists over 65 years were more likely to recommend dialysis than younger nephrologists. 
Overall, nephrologists would forgo 12 months of patient survival to avoid substantial quality of life 
decreases associated with dialysis. 
 
An ACA[17] investigated preferences among 305 US nephrologists for blood transfusion in chronic 
dialysis patients. The analysis incorporated 10 attributes. Findings presented in terms of relative 
16 
 
importance of attributes suggested that haemoglobin level (g/dl) accounted for 29% of decision-
making, followed by functional status (16%), cardiovascular disease (12%), clinical scenario (9%), ESA 
status (9%), age (7%), haemoglobin stability over time (6%), kidney transplant eligibility (5%), iron 
indices (4%), and evidence of occult blood in stool: Fecal Occult Blood Test or Fecal Immunochemical 
Test positive (3%). 
 
Combined dialysis, end-of-life & transplantation  
One Canadian DCE,[18] assessed the preferences of 169 patients, 29 caregivers, and 150 healthcare 
professionals. Dialysis-related attributes included ‘Who provides comprehensive day to day care for 
patients on dialysis?’ and ‘How decisions to stop dialysis should be made’. Transplantation attributes 
included ‘How deceased donor kidneys should be allocated for transplantation’, and ‘How should 
live kidneys for transplantation be obtained?’ Other attributes related to ‘end-of-life’ issues 
including ‘When should end-of-life care discussions commence?’ and ‘How much information on 
prognosis and end-of-life care issues should be routinely provided?’ All the attributes were 
significant, with the exception of some levels for the attribute about who provides comprehensive 
day-to-day care on dialysis.  Regression coefficients suggested that for all respondents early ‘end-of-
life care’ discussions (0.72) were preferred to late (0.00); detailed information on prognosis and end-
of-life care was preferred to limited information (0.56 vs 0.00); whereas medical and personal 
decisions (0.34) as opposed to personal decisions only (0.00) was preferred for decisions about 
stopping dialysis.  
 
In relation to how deceased donor kidneys should be allocated, the ‘best match’ approach (0.81) was 
preferred to ‘first come first served’ (0.00). With respect to how live kidneys for transplantation 
should be obtained, receiving an organ from an unknown donor (-0.43), via a paired kidney exchange 
(-0.80), or buying a kidney (-1.93) were less preferable than receiving a kidney from a family member 
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or close friend (0.00). For the attribute of providing day-to-day dialysis care, the family physician (-
0.51) was less preferable than ‘family physician and group of kidney specialists’ (0.25), whilst the 
‘advanced nurse practitioner and group of kidney specialists’ was non-significant.  
 
Renal cancer studies 
A DCE assessed 120 patients, 52 family members, and 272 healthcare professionals’ preferences for 
targeted renal cell carcinoma therapy in South Korea.[19] The analysis involved 6 attributes. All the 
attributes were significant at the 1% level for patients and health professionals. Additional months 
of progression-free survival were positively valued at 7-31% in terms of relative importance; 
additional months of bone marrow suppression was negatively valued at 18-36%;  the increased 
likelihood of hand-foot skin reaction was negatively valued at 12-23% ; increased likelihood of 
gastrointestinal perforation was valued at between 4-13%: increased risk of bleeding was valued at 
between 11-14%; and administration by injection versus orally was valued at 13-22% in terms of 
relative importance of attributes according to the stakeholder group. 
 
A second DCE assessed benefit-risk preferences for targeted agents in the treatment of renal cell 
carcinoma in 138 US patients.[20]  The respondents faced questions relating to hypothetical renal 
cell carcinoma profiles. The profiles were defined by attributes including efficacy (progression-free 
survival [PFS]), when overall survival was constant), tolerability effects (fatigue / tiredness, 
diarrhoea, hand-foot syndrome, mouth sores) and serious adverse events (liver failure, blood clot). 
Findings suggested PFS was the most important attribute for patients. The remaining attributes were 
ranked in decreasing order of importance: fatigue / tiredness, diarrhoea, liver failure, hand-foot 
syndrome, blood clot, and mouth sores. A key finding was that to increase PFS by 11 months, 
patients would accept a maximum blood clot risk of 3.1% (95%CI 1.5-5.3) or liver failure risk of 2.0% 
(95%CI 1.0-3.3). 
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Discussion 
DCE and CA studies provide several advantages over traditional surveys. First, they provide a 
quantitative estimate of the relative importance of one attribute of a treatment or program 
compared to another, rather than a rating (e.g. Likert scale), or a ranking (simple ordering of 
characteristics from most important to least important). The estimate of relative importance enables 
the researcher to calculate trade-offs, i.e. what amount of one attribute a person is prepared to give 
up in order to gain more of another attribute. This trade-off cannot be calculated from traditional 
surveys. Second, DCE and CA studies allow the estimation of preferences for options that do not yet 
exist. For example, a policy to reimburse a kidney donor for their personal time given to be screened 
for donation, attend the required medical visits, and recover from their donor nephrectomy 
operation. This is possible because DCEs and CAs use hypothetical scenarios containing plausible and 
realistic attributes. Third, DCEs and CAs enable market forecasting of new treatments that can help 
in health service planning. For example, planning integrated renal-palliative care medical services 
based on the proportion of people with end-stage kidney disease who might choose conservative 
kidney management if the alternative were offered to them.  
 
The difficulties of DCEs and CAs compared to other surveys may include the minimum level of 
cognitive ability that is required to comprehend the choice question posed. The cognitive burden is 
considered greater than a simple rating or ranking task. In nephrology, this can be an issue if one 
seeks to elicit preferences from people with advanced chronic kidney disease. A second difficulty 
compared to traditional surveys is the level of statistical or econometric expertise needed in the 
design and analysis of the DCE or CA surveys. At a minimum the analyst needs to have good 
quantitative data skills, familiarity with regression analysis and writing code in statistical software 
such as Nlogit. However the challenges are not insurmountable, as many universities run specific 
19 
 
training courses in DCE design and analysis, and economists/ health economists have applied these 
techniques in different areas now for close to two decades. 
The published literature in nephrology provides important insights about the preferences of key 
stakeholder groups for treatment of kidney disease, highlighting several major implications for 
policy. In kidney transplantation the current allocation criterion of ‘first come first served’ is broadly 
consistent with preference studies, in particular the value placed on ‘equity’ criteria for prioritising 
those who have waited a long time; however other factors not currently considered may be equally 
important. These include the donor status of the patient or family; the number of previous 
transplants; and whether the recipient has child or adult dependents. This would indicate that the 
current allocation policy in many countries may need to change. In dialysis, two separate DCE studies 
identified a preference among patients for longer rather than shorter treatment time (i.e. hours or 
number of days per week) when resulting health benefits could be delivered. This indicates that the 
current minimum standards in international dialysis guidelines for fluid and solute clearance may not 
be aligned with patient preferences, and provision of other modalities such as home dialysis that 
enable increased hours, should be offered.  
Looking to the future, several choice studies in nephrology are planned, including patient 
preferences for kidney transplant monitoring by video-conferencing,[21] preferences for outcomes 
after kidney transplantation,[22] and patient and family preferences for home versus facility-based 
dialysis in New Zealand.[23]  
 
Conclusions 
This review has evaluated the content and methodology of choice studies in nephrology. These 
study designs are increasingly used to obtain information about key preferences in kidney 
transplantation and dialysis. In contrast to other methods they provide quantitative information 
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about respondents’ trade-offs between conflicting objectives, and can establish how policy-relevant 
preferences vary among stakeholder groups. 
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Supplementary Table 1. Type of DCE and number of attributes. 
Authors Non-labelled 
choice 
Labelled 
choice 
Number of 
attributes to 
be seen by 
respondents 
Number of 
attributes is 
2-3 
Number of 
attributes is 
4-5 
Number of 
attributes is 6 
Number of 
attributes is 
7-9 
Number of 
attributes is 
10 
Number of 
attributes is 
>10 
Clark et al 
(2009) 
 - 6 - -  - - - 
Clark et al 
(2012) 
 - 6 - -  - - - 
Davison et al 
(2010) 
 - 6 - -  - - - 
Foote et al 
(2014) 
 - 10 - - - -  - 
Halpern et al 
(2004) 
-  4 -  - - - - 
Howard et al 
(2015a) 
 - 15 - - - - -  
Howard et al 
(2015b) 
 - 8 - - -  - - 
Kjaer et al 
(2012) 
-  3  - - - - - 
Mohamed et 
al (2011) 
 - 7 - - -  - - 
Morton et al 
(2012a) 
 - 7 - - -  - - 
Morton et al 
(2012b) 
 - 7 - - -  - - 
Park et al 
(2012) 
 - 6 - -  - - - 
Reese et al 
(2012) 
-  3  - - - - - 
Whitman et al 
(2013) 
 - 10 - - - -  - 
Total 11 3 - 2 1 4 4 2 1 
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Supplementary Table 2. Details of domains covered by attributes, number of respondent groups, and details of administration of the survey. 
Authors. Attributes 
covered – 
Monetary 
measure 
Attributes 
covered – 
Time 
Attributes 
covered –  
Risk 
Attributes 
covered – 
Health 
status 
domain 
Attributes 
covered – 
Health 
care 
Attributes 
covered - 
Other 
Number of 
main key 
responden
t groups 
Administra
-tion of 
survey – 
Self 
completed 
question-
naires. 
Administra
-tion of 
survey – 
Interview-
er 
administ-
ered 
Administr
ation of 
survey – 
Computer
ized 
review or 
via 
computer 
Administr
ation of 
survey – 
Not 
clearly 
reported 
Clark et al 
(2009) 
-      
11   - - 
Clark et al 
(2012) 
-      4   - - 
Davison et al 
(2010) 
-  -    
3  - - - 
Foote et al 
(2014) 
-      1 - -  - 
Halpern et al 
(2004) 
-  -    
1 
-  - - 
Howard et al 
(2015a) 
-      1 - -  - 
Howard et al 
(2015b) 
 - - -   
1 - -  - 
Kjaer et al 
(2012) 
  - -  - 
1   - - 
Mohamed et 
al (2011) 
-     - 
1 - -  - 
Morton et al 
(2012a) 
  -    
2  - - - 
Morton et al 
(2012b) 
  -    
1  - - - 
Park et al 
(2012) 
-      2    - 
Reese et al 
(2010) 
-      1 - - -  
Whitman et 
al (2013). 
-      2 - -  - 
Total 4 13 8 12 14 12 - 7 5 6 1 
                                                          
1 This paper had one main response group (patients) however sub-group analysis relating to ethnicity and gender was conducted within this sub-group. 
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Supplementary Table 3. Selected details relating to survey instrument design characteristics. 
Authors. Number of 
alternatives 
presented 
No 
information 
about 
number of 
alternatives 
presented. 
Conjoint 
Analysis or 
DCE? 
Adaptive 
Conjoint 
Analysis? 
Best Worst 
Scaling 
Design? 
Number of 
choice sets 
(scenarios) 
presented 
Number of 
choices ≤ 8 
Number of 
choices 
between 9 
and 16 
Number of 
choices > 16 
Number of 
choices not 
clearly 
reported 
Clark et al 
(2009) 
2 -  - - 9 -  - - 
Clark et al 
(2012) 
2 -  - - 9 -  - - 
Davison et al 
(2010) 
2 -  - - 12 -  - - 
Foote et al 
(2014) 
3 -  - - 12 -  - - 
Halpern et al 
(2004) 
2 -  - - 21 - -  - 
Howard et al 
(2015a) 
2 -  - - 30 - -  - 
Howard et al 
(2015b) 
2 -  - - 30 - -  - 
Kjaer et al 
(2012) 
3 -  - - 9 -  - - 
Mohamed et 
al (2011) 
2 -  - - 12 -  - - 
Morton et al 
(2012a) 
3 -  - - 12 -  - - 
Morton et al 
(2012b) 
3 -  - - 12 -  - - 
Park et al 
(2012) 
2 -  - - 10 -  - - 
Reese et al 
(2010) 
2 -  - - 12 -  - - 
Whitman et al 
(2013). 
2 - -  - Not indicated - - -  
Total - 0 13 1 0 - 0 10 3 1 
  
26 
 
Supplementary Table 4. Survey instrument design characteristics.  
Authors.  Design type 
– Full 
Factorial 
Design type 
– Fractional 
Factorial / D 
– efficient 
designs. 
Design type 
not clearly 
reported 
Design plan 
– Main 
effects only 
Design plan 
– Main 
effects and 
two way 
interactions 
Design plan 
– Not 
applicable 
Design plan 
– Not clearly 
reported 
Design 
source – 
Software 
package 
Design 
source – 
Other 
Design 
source – No 
further 
details 
Clark et al 
(2009) 
 --  -  - - - -  - 
Clark et al 
(2012) 
 -  -  - - - -  - 
Davison et al 
(2010) 
 -  - -  - - -  - 
Foote et al 
(2014) 
 -  - -  - -  - - 
Halpern et al 
(2004) 
 -  -  - - -  - - 
Howard et al 
(2015a) 
 -  -  - - -  - - 
Howard et al 
(2015b) 
 -  -  - - -  - - 
Kjaer et al 
(2012) 
 
  - - -  - - - - 
Mohamed et 
al (2011) 
 -  -  - - -  - - 
Morton et al 
(2012a) 
 -  - -  - -  - - 
Morton et al 
(2012b) 
 -  - -  - -  - - 
Park et al 
(2012) 
 -  -  - - - -  - 
Reese et al 
(2010) 
 - -  - - -  - -  
Whitman et al 
(2013). 
 -  -  - - -  - - 
Total  1 12 1 8 4 1 1 8 4 1 
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Supplementary Table 5. Details of design source. 
Authors Design 
source: 
SPEED 
Design 
source:  
SPSS 
Design 
source:   
SAS 
Design 
source: 
Ngene 
Design 
source: 
Sawtooth 
Design 
source: 
Other 
Design 
source: No 
further 
details 
Design source ‘Other’ please describe 
Clark et al 
(2009) 
- 
- - - -  -- 
Street and Burgess design. 
Clark et al 
(2012) 
- 
- - - -  - 
Street and Burgess design. 
Davison et al 
(2010) 
- 
- - - -  - 
Street and Burgess design. 
Foote et al 
(2014) 
- 
- -  - - - 
- 
Halpern et al 
(2004) 
- 
- - - - -  
- 
Howard et al 
(2015a) 
- 
- -  - - - 
- 
Howard et al 
(2015b) 
- 
- -  -- - - 
- 
Kjaer et al 
(2012) 
- 
- - - -  - 
Design template was the full factorial. 
Mohamed et 
al (2011) 
- 
- - - -  - 
Gauss version 7 – D-efficient design. 
Morton et al 
(2012a) 
- 
- -  - - - 
- 
Morton et al 
(2012b) 
- 
- -  - - - 
- 
Park et al 
(2012) 
- 
- - - -  - 
Sloans library of orthogonal arrays. 
Reese et al 
(2010) 
- 
- - - - -  
- 
Whitman et 
al (2013) 
- 
- - - -  - 
ACBC Adaptive Conjoint Analysis design. 
Total 0 0 0 5 0 7 2 - 
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Supplementary Table 6.  Further details of design source, methods to create choice sets. 
Authors Design 
source: 
Catalogue 
Design 
source:  
Website 
Design 
source: Expert 
Design 
source: Not 
clearly 
reported 
Methods to 
create choice 
sets – 
Orthogonal 
arrays single 
profiles 
Methods to 
create choice 
sets – 
Orthogonal 
arrays 
random 
pairing 
Methods to 
create choice 
sets – 
Orthogonal 
arrays pairing 
with a 
constant 
comparator 
Methods to 
create choice 
sets – 
Orthogonal 
arrays 
foldover with 
random 
pairing 
Methods to 
create choice 
sets – 
Orthogonal 
arrays 
foldover 
Clark et al 
(2009) 
- -  - - - - -  
Clark et al 
(2012) 
- -  - - - - -  
Davison et al 
(2010) 
- -  - - - - - - 
Foote et al 
(2014) 
- - - - - - - - - 
Halpern et al 
(2004) 
- - -  - - - - - 
Howard et al 
(2015a) 
- - - - - - - - - 
Howard et al 
(2015b) 
- - - - - - - - - 
Kjaer et al 
(2012) 
-- - - - - - - - - 
Mohamed et 
al (2011) 
- - - - - - - - - 
Morton et al 
(2012a) 
- - - - - - - - - 
Morton et al 
(2012b) 
- - - - - - - - - 
Park et al 
(2012) 
-  - - - - - -  
Reese et al 
(2010) 
- - -  - - - - - 
Whitman et al 
(2013) 
- - - - - - - - - 
Total 0 1 3 2 0 0 0 0 3 
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Supplementary Table 7. Methods used to create choice sets. 
Authors Methods used to 
create choice 
sets: Orthogonal 
arrays D-
efficiency (SAS). 
Methods used to 
create choice 
sets: Orthogonal 
arrays D-
efficiency 
(NGENE). 
Methods used to 
create choice 
sets: Orthogonal 
arrays D-
efficiency 
(Other). 
Methods used to 
create choice 
sets: Orthogonal 
arrays – Other 
pragmatically 
chosen. 
Methods used 
to create choice 
sets: Orthogonal 
arrays – Not 
clearly reported. 
Methods used to create choice 
sets: Other with details if 
applicable. 
Clark et al 
(2009) 
- - - - - - 
Clark et al 
(2012) 
- - - - - - 
Davison et al 
(2010) 
- - - -  - 
Foote et al 
(2014) 
-  - - - - 
Halpern et al 
(2004) 
- - -  - - 
Howard et al 
(2015a) 
-  - - - - 
Howard et al 
(2015b) 
-  - - - - 
Kjaer et al 
(2012) 
- - - - - Full factorial 
Mohamed et 
al (2011) 
- - 
 
Gauss 
- - - 
Morton et al 
(2012a) 
-  - - - - 
Morton et al 
(2012b) 
-  - - - - 
Park et al 
(2012) 
- - - - - - 
Reese et al 
(2010) 
- - - -  - 
Whitman et al 
(2013) - - - - - 
 Known as ACBC adaptive 
conjoint analysis 
Total 0 5 1 1 2 2 
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Supplementary Table 8. Details of the DCE estimation procedure. 
Authors Estimation 
procedure – 
Probit.  
Estimation 
procedure – 
Random Effects 
Probit. 
Estimation 
procedure – 
Logit. 
Estimation 
procedure - 
Random Effects 
Logit. 
Estimation 
procedure – MNL 
/ Conditional 
Logit 
Estimation 
procedure – 
Nested Logit 
Estimation 
procedure - 
Random 
Parameter Logit 
or Mixed Logit 
(MXL) 
Clark et al 
(2009) 
-  - - - - - 
Clark et al 
(2012) 
-  - - - - - 
Davison et al 
(2010) 
- - - -  - - 
Foote et al 
(2014) 
- - - - - -  
Halpern et al 
(2004) 
- -  - - - - 
Howard et al 
(2015a) 
- - - - - -  
Howard et al 
(2015b) 
- - - - - -  
Kjaer et al 
(2012) 
- - - - - -  
Mohamed et 
al (2011) 
- - - - - -  
Morton et al 
(2012a) 
- - - - - -  
Morton et al 
(2012b) 
- - - - - -  
Park et al 
(2012) 
- - - -  - - 
Reese et al 
(2010) 
-- -  - - - - 
Whitman et al 
(2013) 
- - - - - - - 
Total 0 2 2 0 2 0 7 
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Supplementary Table 9. Details of estimation procedure (continued). 
Authors Estimation 
procedure – 
Generalized 
Mixed Logit  
Estimation 
procedure – 
Generalized 
Multinomial 
Logit. 
Estimation 
procedure – 
Latent Class. 
Estimation 
procedure – 
Other. 
Mixed Logit / 
Random 
Parameter 
Logit / Latent 
Class 
Generalized 
Multinomial 
Logit / 
Generalized 
Mixed Logit -
Evidence of 
preference 
heterogeneity. 
Is number of 
replications 
specified 
when 
applicable? 
Mixed Logit / 
Random 
Parameter 
Logit / 
Generalized 
Multinomial 
Logit / 
Generalized 
Mixed Logit – 
Normal. 
Mixed Logit / 
Random 
Parameter 
Logit / 
Generalized 
Multinomial 
Logit / 
Generalized 
Mixed Logit– 
Logs. 
Mixed Logit / 
Random 
Parameter 
Logit / 
Generalized 
Multinomial 
Logit / 
Generalized 
Mixed Logit– 
Other 
distribution. 
Clark et al 
(2009) 
- - - - - - - - - 
Clark et al 
(2012) 
- - - - - - - - - 
Davison et al 
(2010) 
- - - - - - - - - 
Foote et al 
(2014) 
- - - -    - - 
Halpern et al 
(2004) 
- - - - - - - - - 
Howard et al 
(2015a) 
- - - -    - - 
Howard et al 
(2015b) 
- -  -    - - 
Kjaer et al 
(2012) 
- - - -     - 
Mohamed et 
al (2011) 
- - - -  -  - - 
Morton et al 
(2012a) 
- - - -  - - - - 
Morton et al 
(2012b) 
- - - -  - - - - 
Park et al 
(2012) 
- - - - - - - - - 
Reese et al 
(2010) 
- - - - - - - - - 
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Whitman et al 
(2013) 
- - - 
 (ACBC part-
worth utility) - 
- - - - 
Total 
0 0 1 1 
7 
 
4 5 1 0 
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Supplementary Table 10. Reporting of preference heterogeneity. 
Authors Methods for 
preference 
heterogeneity 
used 
Details of methods for preference heterogeneity 
Clark et al 
(2009) 
 Interaction dummy variables to establish whether patient preferences varied by gender (Male vs. Female) and ethnicity (non-
white ethnic minority patients vs. other patients; South Asian vs. other patients). Wald tests for differences in MRS. 
Clark et al 
(2012)  
Interaction dummy variables to establish whether stakeholder group preferences for healthcare professionals, carers, live donors 
/ relatives of deceased donors, varied from the patient group. Also interaction dummies to establish whether patient preferences 
varied between ethnic minority patients and non-ethnic minority patients. Wald tests for differences in MRS. 
Davison et al 
(2010) 
 Results presented separately for whole sample, healthcare providers, and patients and caregivers. 
Foote et al 
(2014) 
 A Mixed Logit / Random Parameters Logit was applied which allows some investigation of preference heterogeneity. 
Halpern et al 
(2004)  
They included in the multivariable model each patient-level variable that had univariable associations with the willingness to 
switch to daily hemodialysis at the level of P<0.25. Patients who might consider switching were younger (mean age 50.9 vs. 60.1, 
P=0.0003) than those who would not.  
Howard et al 
(2015a) 
 A Mixed Logit model was applied which allowed for some investigation of preference heterogeneity. 
Howard et al 
(2015b)  
In addition to a Mixed Logit Model a Latent Class Model was applied. To explore associations with class membership respondent’s 
sociodemographic characteristics were entered into the model one at a time. Any characteristics that was significant at P < 0.1 
level and resulted in equal or improved model fit (Akaike Information Criteria) was retained. 
Kjaer et al 
(2012) 
 Used Random Parameter Logit, and also conducted a separate econometric model for respondents not choosing the status quo. 
Mohamed et 
al (2011) 
 A Mixed Logit / Random Parameters Logit was applied which allows some investigation of preference heterogeneity. 
Morton et al 
(2012a) 
 A Mixed Logit model was applied and sociodemographic characteristics were incorporated into each model as separate variables 
/ interaction terms.  
Morton et al 
(2012b) 
 A Mixed Logit model was applied and sociodemographic characteristics were incorporated into each model as separate variables 
/ interaction terms. 
Park et al 
(2012) 
 Separate conditional logit models for the different sub-groups, including the patient group, and healthcare professional group. 
Also assessment of whether patient and healthcare professional results varied in a statistically significant manner. 
Reese et al 
(2010) 
 Likelihood of accepting a ‘Donor at Increased Risk for blood borne Viral Infection’ (DIRVI) according to the patient samples 
characteristics was established. 
Whitman et al 
(2013)  
Results of the adaptive conjoint analysis were presented. Influence of being a non-Nephrologists vs. Nephrologist about whether 
you believed patient transplant eligibility should influence transfusion decisions in chronic kidney disease (CKD). Also the 
influence of other provider characteristics [higher monthly expenditure on dialysis, and years of practice experience] upon 
whether transplant eligibility should influence transfusion decisions. 
- 14 - 
 
34 
 
Supplementary Table 11. Validity tests. 
Authors. Validity tests 
– External.2 
Validity tests – 
Internal -  
Theoretical.3 
Validity tests 
– Internal – 
Non-
satiation.4 
Validity tests 
– Internal – 
Transitivity.5 
Validity tests 
– Internal – 
Sens 
expansion 
and 
contraction 
criteria.6 
Validity tests 
– Internal – 
Compensatory 
decision 
making.7 
Validity tests 
– Use of 
qualitative 
methods to 
enhance DCE 
process and 
results: 
Attribute 
selection. 
Validity tests 
– Use of 
qualitative 
methods to 
enhance DCE 
process and 
results: Level 
selection. 
Validity tests 
– Use of 
qualitative 
methods to 
enhance DCE 
process and 
results: Pre-
testing 
questionnaire. 
Clark et al 
(2009) 
-  - - - -    
Clark et al 
(2012) 
-  - - - --    
Davison et al 
(2010) 
-  - - - - - - - 
Foote et al 
(2014) 
-  - - - -    
Halpern et al 
(2004) 
-  - - - - - -  
Howard et al 
(2015a) 
-  - - - -    
Howard et al 
(2015b) 
-  - - - -    
                                                          
2 External validity requires a comparison of stated preference results from DCE, CA, or ACA with revealed preferences. 
3 Theoretical validity requires that some assessment is made of whether the signs attached to significant attributes make intuitive sense, or are in line with prior expectations. 
4 Non-satiation requires that if, for any amount of a good or service, more is preferred to less, then more will be preferred to less also at all larger amounts of that good or service. 
5 Transitivity suggests that if a<b and b<c then a<c.   
6 These criteria are stated formally on P500 of the paper by Sen (1993). The expansion consistency property (property ϒ) requires that an element x that is chosen from every set in a 
particular class must be chosen also from the union. The basic contraction consistency property (property α) demands that an alternative which is chosen from a set S and belongs to subset 
T of S must be chosen from T as well.  The citation for the paper by Sen (1993) is: 
Sen A. Internal consistency of choice. Econometrica. 1993. 61: 495-521. 
7 In compensatory decisions, when the final values for attributes are computed, negative attributes can be compensated for by equal or higher value positive attributes. 
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Kjaer et al 
(2012) 
-  - - - - - -  
Mohamed et 
al (2011) 
-  - - -     
Morton et al 
(2012a) 
-  - - - -    
Morton et al 
(2012b) 
-  - - - -    
Park et al 
(2012) 
-   - - - - - - 
Reese et al 
(2010) 
-  - - - -    
Whitman et 
al (2013) 
-  - - - - - - - 
Total 0 14 1 0 0 1 9 9 11 
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Supplementary Table 12. Validity tests (further details). 
Authors Validity tests – 
Use of 
qualitative 
methods to 
enhance DCE 
process and 
results – 
Strengthening 
understanding 
through de-
briefing 
choices. 
Validity tests – 
Other 
Details of other validity tests Validity tests – 
none apparent 
Clark et al 
(2009) 
- - - - 
Clark et al 
(2012) 
- - - - 
Davison et al 
(2010) 
- - - - 
Foote et al 
(2014) 
- - - - 
Halpern et al 
(2004) -  
They claim “we assessed patients’ adherence to monotonicity – the principle that patients 
should never be more willing to switch when a lower level of one attribute is offered while 
levels of other attributes are held constant.” 
- 
Howard et al 
(2015a) 
- - - - 
Howard et al 
(2015b) 
- - - - 
Kjaer et al 
(2012) 
-  Collected information about respondents self-perceived difficulty in completing DCE 
questionnaires (whether easy, difficult, or very difficult). 
- 
Mohamed et 
al (2011) 
  Pilot ‘think aloud’ exercise with attention paid to whether simplifying heuristics might be  
deployed. 
- 
Morton et al 
(2012a) 
  A practice question was included before the 12 DCE questions. 
 
- 
Morton et al 
(2012b)   
A practice question was included before the 12 DCE questions, and a secondary analysis of 
75 patients who answered the practice question correctly showed no significant 
differences to the main analysis. 
 
- 
Park et al 
(2012) 
-  DCE results were considered alongside a ranking (P936) of adverse events (in order of 
severity) undertaken by doctors and nurses. 
- 
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Reese et al 
(2010) 
- - - - 
Whitman et al 
(2013) 
- - - - 
Total 3 6 - 0 
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Supplementary Table 13. Main objectives and output of DCEs. 
Authors. A. Patient 
consumer 
experience. 
B. Valuing 
Health 
Outcomes. 
C. Investigate 
trade-offs 
between 
health 
outcomes 
and patient 
or consumer 
experience 
factors 
D. Estimating 
utility 
weights 
within the 
QALY 
framework 
E. Job choices 
for 
preferences 
relating to 
medical posts 
or healthcare 
human 
resource 
policy. 
F. Developing 
priority 
setting 
frameworks 
G. Health 
professionals 
preferences 
for treatment 
or screening 
options for 
patients 
H. Other Total number 
of objectives 
per analysis. 
Clark et al 
(2009) 
- - - - -  - - 1 
Clark et al 
(2012) 
- - - - -  - - 1 
Davison et al 
(2010) 
- - - - -  - - 1 
Foote et al 
(2014) 
- - - - - -  - 1 
Halpern et al 
(2004) 
- -  - - - - - 1 
Howard et al 
(2015a) 
- - - - -  - - 1 
Howard et al 
(2015b) 
- - - - - - -  1 
Kjaer et al 
(2012) 
- - - - -  - - 1 
Mohamed et 
al (2011) 
- -  - - - - - 1 
Morton et al 
(2012a) 
- -  - - - - - 1 
Morton et al 
(2012b) 
- -  - - - - - 1 
Park et al 
(2012) 
- -  - - -  - 2 
Reese et al 
(2010) 
- - - - -  - - 1 
Whitman et al 
(2013) 
- - - - - -  - 1 
Total 0 0 5 0 0 6 3 1 - 
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Supplementary Table 14. Presentation of key findings for applied use. 
Authors. Per 
Willingness 
to Pay Unit. 
Per time 
period. 
Per risk 
unit. 
Monetary 
welfare 
measure. 
Utility 
score. 
Odds ratio. Probability 
score. 
Other (described) 
Clark et al 
(2009) 
--  - - - - - - 
Clark et al 
(2012) 
-  - - - - - - 
Davison et al 
(2010) - - - - - - - 
 Rank order importance of 
attributes. 
Foote et al 
(2014) 
- - - - -  - - 
Halpern et al 
(2004) 
- - - - - - -  Willingness to switch dialysis. 
Howard et al 
(2015a) 
- - - - -  -  Odds ratio of receiving an organ. 
Howard et al 
(2015b) - - - - -  - 
 Odds ratio of preferring new to 
current policy 
Kjaer et al 
(2012) 
 - - - - - - - 
Mohamed et 
al (2011) - - - - - - - 
 Marginal rate of substitution 
with respect to progression-free 
survival [PFS]. 
Morton et al 
(2012a) 
- - - - -  - 
 Willingness to trade life 
expectancy to improve another 
attribute. 
Morton et al 
(2012b) 
- - - - -  - 
 Prefer conservative care or 
dialysis (odds ratios). 
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Park et al 
(2012) 
- - - - -  - 
 Relative importance of attributes 
and Marginal rates of substitution 
between attributes. 
 
Reese et al 
(2010) - - - - -  - 
 Willingness to accept a kidney 
from a donor at Increased Risk of 
blood borne Viral Infection (DIRVI) 
Whitman et al 
(2013) 
- - - - -  - - 
Total 1 2 0 0 0 8 0 9 
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Supplementary Table 15: Was information collated relating to the ethnicity or language group of respondents, and was data analysis relating to ethnicity and language 
group conducted? 
Authors Was information collated about ethnicity and language groups Are findings presented in terms or ethnicity / language group? 
Clark et al 
(2009) 
Yes: Information collated about the ethnic group of patients. Yes: Amongst non-white ethnic minorities having a close match between 
donor and recipient was not significantly valued. However, amongst 
patients who were not in this ethnic group having a close match between 
donor and recipient was positively valued 
Clark et al 
(2012) 
Yes:  Information collated about the ethnic group of patients. Yes: Amongst South Asian ethnic minorities, and for a more general ethnic 
minority group having a close match between donor and recipient was not 
significantly valued. However, amongst patients who were not in these 
ethnic groups having a close match between donor and recipient was 
positively valued 
Davison et al 
(2010) 
Yes: Compiled information about the racial profile of the sample (e.g. 
percentage white, percentage other, and percentage missing responses). 
No: Sub-group analysis according to the race of respondents was not 
reported. 
Foote et al 
(2014) 
Yes: Compiled information about the racial profile of the sample (e.g, 
number and percentage by ethnicity [Caucasian, Asian, Arab, and Other]).  
Yes: The ethnicity of Nephrologist respondents was found to have no 
significant effect upon preferences for recommendation of dialysis to 
elderly patients. 
Halpern et al 
(2004) 
Yes: Information upon the racial profile of the sample was compiled (e.g. 
non-hispanic black, non-hispanic white, and other). 
Yes: The findings of the data analysis suggested that race was not 
independently a significant determinant of willingness to switch renal 
dialysis regimen. 
Howard et al 
(2015a) 
Yes: The study reported information about whether respondents English at 
home. 
No: This language group information did not appear to be used to 
underpin sub-group data analysis. 
Howard et al 
(2015b) 
Yes: Information about whether respondents spoke English at home, and 
also whether respondents spoke a second language at home (e.g. Mandarin, 
Cantonese, Italian, Vietnamese, Greek, and Arabic. 
Yes: Results of the latent class analysis did not suggest that language 
group was a significant determinant of latent class membership (and 
hence of preferences). 
Kjaer et al 
(2012) 
No: No information about ethnic group or language group was collated. No: It did not conduct ethnicity or language group analysis. However the 
questionnaire was professionally translated from Danish to Greenlandic.  
Mohamed et 
al (2011) 
Yes: Information was collated about the number of respondents who were 
African American, Caucasian, or of other ethnicity. 
No: The impact of race upon DCE findings was not considered. 
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Morton et al 
(2012a) 
No: No information about ethnic group or language group was collated. No: No analysis relating to ethnic group or language group was conducted. 
Morton et al 
(2012b) 
No: No information about ethnic group or language group was collated. No: No analysis relating to ethnic group or language group was conducted. 
Park et al 
(2012) 
No: No information about ethnic group or language group was collated. No: No analysis relating to ethnic group or language group was conducted. 
Reese et al 
(2012) 
Yes: Information about the racial profile of people (e.g. White, African 
American, Hispanic, and Other). 
Yes: Unadjusted data analyses suggested that being of black race, was 
associated with greater likelihood of accepting a kidney from a donor at 
increased risk of blood-borne viral infection. 
Whitman et 
al (2013) 
No: No information about ethnic group or language group was collated. No: No analysis relating to ethnic group or language group was conducted. 
 
